Product Information
DIOVAN HCT 320-25 MG TABLET is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $16.4965 per EA under NDC 00078047234. Its NADAC has been published 394 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the valsartan and hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25; 320 mg/1; mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078047234
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/7/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; VALSARTANApproval Type
New Drug (NDA)
FDA Application
NDA020818On Market Since
4/28/2006
Pharmacological Classes
Price Statistics
The NADAC for DIOVAN HCT 320-25 MG TABLET has been published 394 times since Nov 28, 2013, and over the history we have for it it has risen 171.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.4965 per EA |
|---|---|
| All-time high | $16.4965 (Mar 11, 2026) |
| All-time low | $6.0854 (Nov 28, 2013) |
| 52-week high | $16.4965 |
| 52-week low | $16.0160 |
| Median price | $11.5100 |
| Average price | $11.4588 |
| Largest weekly change | +17.4% (Oct 23, 2024) |
| Weeks tracked | 394 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DIOVAN HCT 320-25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DIOVAN HCT 320-25 MG TABLET, manufactured by Novartis Pharmaceuticals Corporation, is $16.4965 per EA (NDC 00078047234), effective Mar 11, 2026.
How has the price of DIOVAN HCT 320-25 MG TABLET changed over time?
Over the history we have for it, the NADAC for DIOVAN HCT 320-25 MG TABLET has risen 171.1%. It has been tracked across 394 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DIOVAN HCT 320-25 MG TABLET?
Since Nov 28, 2013, the NADAC for DIOVAN HCT 320-25 MG TABLET has ranged from a low of $6.0854 (Nov 28, 2013) to a high of $16.4965 (Mar 11, 2026), with a median of $11.5100 per EA.
Are there cheaper alternatives to DIOVAN HCT 320-25 MG TABLET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB, is $0.2143 per EA — about 99% below DIOVAN HCT 320-25 MG TABLET.
Who manufactures DIOVAN HCT 320-25 MG TABLET?
DIOVAN HCT 320-25 MG TABLET (NDC 00078047234) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification